Maksim E. ZAPOLSKI,Margarita A. MOROZOVA,Allan G. BENIASHVILI
申请号：
US15455880
公开号：
US20170196883A1
申请日:
2017.03.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This present disclosure generally relates to medicine, and in particular to pharmacology and psychiatry, and discloses active agents and related methods of treatment which can be used for the treatment of treatment-resistant forms of schizophrenia. In some exemplary aspects, such treatments allow for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, without causing severe side effects that limit their use, such as sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.
